12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Solorel regulatory update

Aeterna Zentaris submitted an NDA to FDA for Solorel macimorelin to diagnose adult growth hormone deficiency (GHD). Last year, Aeterna Zentaris...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >